Cargando…

Etiology and Prognosis of Cardiogenic Shock in a Secondary Center without Surgical Back-Up

BACKGROUND: Cardiogenic shock (CS) remains a major challenge in contemporary cardiology. Data regarding CS etiologies and their prognosis are limited and mainly derived from tertiary referral centers. AIMS: To investigate the current etiologies of cardiogenic shock and their associated short- and lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonello, Laurent, Laine, Marc, Puymirat, Etienne, Ceccaldi, Victoria, Gaubert, Mélanie, Paganelli, Franck, Thuny, Pr Franck, Dabry, Thibaut, Schurtz, Guillaume, Delmas, Clement, Mancini, Julien, Lemesle, Gilles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925788/ https://www.ncbi.nlm.nih.gov/pubmed/31885900 http://dx.doi.org/10.1155/2019/3869603

Ejemplares similares

Hemodynamic Profiles of Cardiogenic Shock Depending on Their Etiology
por: Gaubert, Mélanie, et al.
Publicado: (2020)

IMPELLA(®) or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock
por: Schurtz, Guillaume, et al.
Publicado: (2021)

Impact of Pre-Existing History of Heart Failure on Patient Profile, Therapeutic Management, and Prognosis in Cardiogenic Shock: Insights from the FRENSHOCK Registry
por: Schurtz, Guillaume, et al.
Publicado: (2022)

Intensified immunosuppressive therapy in patients with immune checkpoint inhibitor-induced myocarditis
por: Cautela, Jennifer, et al.
Publicado: (2020)

Acute Coronary Syndrome in the Era of SARS-CoV-2 Infection: A Registry of the French Group of Acute Cardiac Care
por: Koutsoukis, Athanasios, et al.
Publicado: (2020)

Mottling as a prognosis marker in cardiogenic shock
por: Merdji, Hamid, et al.
Publicado: (2023)

Beta-blocker management in patients admitted for acute heart failure and reduced ejection fraction: a review and expert consensus opinion
por: Schurtz, Guillaume, et al.
Publicado: (2023)

Wearable cardioverter defibrillator: Bridge or alternative to implantation?
por: Barraud, Jeremie, et al.
Publicado: (2017)

One-year outcomes in cardiogenic shock triggered by supraventricular tachycardia: an analysis of the FRENSHOCK multicenter prospective registry
por: Cherbi, Miloud, et al.
Publicado: (2023)

Baseline characteristics, management, and predictors of early mortality in cardiogenic shock: insights from the FRENSHOCK registry
por: Delmas, Clement, et al.
Publicado: (2021)

One-year outcomes in cardiogenic shock triggered by ventricular arrhythmia: An analysis of the FRENSHOCK multicenter prospective registry
por: Cherbi, Miloud, et al.
Publicado: (2023)

Early Evaluation of Patients on Axial Flow Pump Support for Refractory Cardiogenic Shock Is Associated with Left Ventricular Recovery
por: Fagot, Jérôme, et al.
Publicado: (2020)

Diagnostic Value of the International Society of Cardio‐Oncology Definition for Suspected Immune Checkpoint Inhibitor–Associated Myocarditis
por: Deharo, Francois, et al.
Publicado: (2023)

Cardiogenic shock among cancer patients
por: Curtiaud, Anais, et al.
Publicado: (2022)

Escalation and de-escalation of mechanical circulatory support in cardiogenic shock
por: Bertoldi, Letizia F, et al.
Publicado: (2021)

Acute coronary syndromes in the era of SARS-CoV-2 Infection: A registry of the French group of acute cardiac care
por: Koutsoukis, A., et al.
Publicado: (2021)

Biodegradable polymer Biolimus-eluting stent (Nobori®) for the treatment of coronary artery lesions: review of concept and clinical results
por: Schurtz, Guillaume, et al.
Publicado: (2014)

Extended emphysematous aortitis of the ascending aorta: An unusual fatal presentation of aortic valve endocarditis due to Clostridium Septicum
por: Dubois, Denis, et al.
Publicado: (2022)

Cardioprotective shock management: monitoring and supportive therapies
por: Schibilsky, David, et al.
Publicado: (2021)

Relative impact of bleedings over ischaemic events in patients with heart failure: insights from the CARDIONOR registry
por: Lemesle, Gilles, et al.
Publicado: (2020)

High incidence of atrial fibrillation in patients treated with ibrutinib
por: Baptiste, Florian, et al.
Publicado: (2019)

Successful Reversal of Severe Tachycardia-Induced Cardiomyopathy with Cardiogenic Shock by Urgent Rhythm or Rate Control: Only Rhythm and Rate Matter
por: Volle, Kim, et al.
Publicado: (2021)

Budget Impact Analysis of Impella CP(®) Utilization in the Management of Cardiogenic Shock in France: A Health Economic Analysis
por: Delmas, Clément, et al.
Publicado: (2022)

Budget Impact Associated with the Introduction of the Impella 5.0(®) Mechanical Circulatory Support Device for Cardiogenic Shock in France
por: Le Guyader, Alexandre, et al.
Publicado: (2021)

The 50‐year‐old pulmonary artery catheter: the tale of a foretold death?
por: Leurent, Guillaume, et al.
Publicado: (2020)

Cardiogenic shock /
Publicado: (2002)

Cardiogenic Shock
por: Vahdatpour, Cyrus, et al.
Publicado: (2019)

Impella CP Implantation during Cardiopulmonary Resuscitation for Cardiac Arrest: A Multicenter Experience
por: Panagides, Vassili, et al.
Publicado: (2021)

Extracorporeal life support for refractory cardiogenic shock. etiology and outcome in a tertiary referral hospital
por: Hurtado-Doce, AI, et al.
Publicado: (2015)

Cardiogenic Shock Secondary to Acute Mitral Regurgitation With Nonischemic Etiology Successfully Stabilized by Transcatheter Intervention
por: Zhang, Jiandong, et al.
Publicado: (2022)

New Insights in Early Detection of Anticancer Drug-Related Cardiotoxicity Using Perfusion and Metabolic Imaging
por: Cadour, Farah, et al.
Publicado: (2022)

Impact of Platelet Reactivity in ACS Patients on Clinical Outcomes with Triple Antithrombotic Therapy
por: Gruttemeier, Julia, et al.
Publicado: (2021)

Effect of Cardiogenic Shock Hospital Volume on Mortality in Patients With Cardiogenic Shock
por: Shaefi, Shahzad, et al.
Publicado: (2015)

What Is the Evidence of the Diagnostic Criteria and Screening of Immune Checkpoint Inhibitor–Induced Myocarditis?
por: Thuny, Franck, et al.
Publicado: (2022)

Early Prediction of 3-month Survival of Patients in Refractory Cardiogenic Shock and Cardiac Arrest on Extracorporeal Life Support
por: Delmas, Clément, et al.
Publicado: (2017)

CARDIOGENIC SHOCK WITH IMIPRAMINE
por: Chaudhury, S., et al.
Publicado: (1990)

Hypothermia in cardiogenic shock
por: van der Pals, Jesper
Publicado: (2012)

Phenotyping Cardiogenic Shock
por: Zweck, Elric, et al.
Publicado: (2021)

Low-dose corticosteroid therapy for cardiogenic shock in adults (COCCA): study protocol for a randomized controlled trial
por: Mekontso Dessap, Armand, et al.
Publicado: (2022)

Effectiveness and Safety of a Prolonged Hemodynamic Support by the IVAC2L System in Healthy and Cardiogenic Shock Pigs
por: Delmas, Clément, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2ek3emvqc8gfm1breq604n3s84